ロード中...
Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy
First-line chemotherapy to combat primary malignant brain cancer is often accompanied by lymphopenic immunologic deficiency. Although counterintuitive, chemotherapy-induced lymphopenia can provide excellent host conditioning that may actually be leveraged to potentiate antitumor immunotherapy. We di...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292586/ https://ncbi.nlm.nih.gov/pubmed/25610727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.944054 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|